A medical doctor reported via a Biogen employee (area business manager) that a 35 year old male patient on 
TYSABRI (unknown dosing regimen) for an unknown indication from unknown date to unknown date for 4 years, 
died on(b) (6)  The cause of death is unknown. The patient was test positive for anti JCV antibodies with in 
index of 1.3 in Apr 2014 and 1.9 in Sep 2014. In Feb 2015 the neuroradiologist diagnosed progressive MS due to 
the lesions, not PML. The patient has had a lot of scans done since Sep [2014]. A lumbar puncture was sent (no 
further details) and a negative result returned.  The causality for the event of death was assessed as related. It is 
unknown if TYSABRI therapy was ongoing at the time of death.
Update 30 Jun 2015: The same doctor spontaneously reported that the 34 year old patient on TYSABRI from 28 
Nov 2011 to 10 Feb 2015 experienced suspected PML symptoms including dysarthria, dysphagia, ataxia and 
ophthalmoplegia in Sep 2014. At the time of this report, the patient had received a total of 43 doses of TYSABRI 
infusion from 28 Nov 2011 to 10 Feb 2015. MS was diagnosed in Sep 2011 with symptom onset in 2008. The 
patient had no prior exposure to disease modifying therapy. The patient was tested positive for anti JCV antibodies 
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 89 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
on 02 Nov 2012 with an index of 1.37 and on 23 Sep 2014 with an index of 2.004. The patient's EDSS was 6.0 prior
to TYSABRI, 6.0 on TYSABRI and 6.5 at the time of PML suspicion. MRIs prompting PML suspicion included ones 
performed on 23 Sep 2014, 22 Oct 2014, 18 Dec 2014 and potential one on 17 Feb 2015. The impression [of MRI] 
is brainstem relapse of MS. MRIs at the time of PML suspicion included ones performed on 04 Mar 2015, 13 Mar 
2015, 20 Mar 2015, 26 Mar 2015 and 01 Apr 2015 which showed progressive single brainstem lesion. MS lesion 
unchanged. Lumbar puncture was done on 23 Sep 2014, 18 Feb 2015, 25 Mar 2015 and 24 Apr 2015 and CSF 
was tested at a local lab. The CSF sample from 23 Sep 2014 was tested negative but the other three were positive 
for JCV [DNA]. The patient did not receive PLEX. The patient died on (b) (6)  (discrepant date) and the final 
diagnosis is PML.